Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Payables (2016 - 2019)

Historic Payables for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $1.7 million.

  • Soleno Therapeutics' Payables rose 3935.74% to $1.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.7 million, marking a year-over-year increase of 3935.74%. This contributed to the annual value of $934000.0 for FY2018, which is 4755.13% up from last year.
  • According to the latest figures from Q3 2019, Soleno Therapeutics' Payables is $1.7 million, which was up 3935.74% from $1.7 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Payables ranged from a high of $1.7 million in Q2 2019 and a low of $410512.0 during Q4 2016
  • Over the past 5 years, Soleno Therapeutics' median Payables value was $957000.0 (recorded in 2016), while the average stood at $1.0 million.
  • Examining YoY changes over the last 5 years, Soleno Therapeutics' Payables showed a top increase of 10322.06% in 2016 and a maximum decrease of 4093.83% in 2016.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Payables stood at $695056.0 in 2015, then crashed by 40.94% to $410512.0 in 2016, then soared by 54.2% to $633000.0 in 2017, then skyrocketed by 47.55% to $934000.0 in 2018, then surged by 85.76% to $1.7 million in 2019.
  • Its Payables was $1.7 million in Q3 2019, compared to $1.7 million in Q2 2019 and $1.3 million in Q1 2019.